Code | 1216B | ||||||||||
MA number | 27/0295/14-S | ||||||||||
Product Form: | tbl flm 130x100 mg/25 mg/200 mg (obal HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | HDPE tablet container | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 27.08.2014 |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 23.11.2020 |